[Cytomegalovirus and BK polyomavirus infection after renal transplantation].
Cytomegalovirus (CMV) and BK polyomavirus (BKV) infections have been described in a high percentage of renal transplant patients and are known to cause various complications in renal transplantation. They are closely related to immunosuppressive therapy and implicated in the progression of graft failure. This review focuses on the clinical aspects of CMV and BKV infection after renal transplantation, optimal monitoring, and recent preventive measures and interventions to improve graft function and recipient survival.
De Paolis
P
P
U.O.C. Nefrologia, Dialisi e Trapianto, Polo Ospedaliero Interaziendale Trapianti, A.O. S. Camillo-Forlanini, INMI L. Spallanzani, Roma 00151, Italy. digiulio@tin.it
Gervasio
E
E
Tedesco
M
M
Favaro'
A
A
Iappelli
M
M
Di Giulio
S
S
D000998:Antiviral Agents / Q000627:therapeutic use; D001739:BK Virus / Q000302:isolation & purification*; D003587:Cytomegalovirus / Q000302:isolation & purification*; D003586:Cytomegalovirus Infections / Q000175:diagnosis* / Q000188:drug therapy; D019317:Evidence-Based Medicine; D006084:Graft Rejection / Q000517:prevention & control; D006085:Graft Survival; D006801:Humans; D016867:Immunocompromised Host; D007674:Kidney Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000821:virology*; D016030:Kidney Transplantation; D027601:Polyomavirus Infections / Q000175:diagnosis* / Q000188:drug therapy; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D014412:Tumor Virus Infections / Q000175:diagnosis* / Q000188:drug therapy
D000998:Antiviral Agents